Literature DB >> 12349830

Pamidronate after heart transplantation.

S Tüzün.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12349830     DOI： 10.1007/s001980200104

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  3 in total

1.  Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.

Authors:  M A Krieg; C Seydoux; L Sandini; J J Goy; D G Berguer; D Thiébaud; P Burckhardt
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

2.  Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy.

Authors:  M Kraj; R Pogłód; J Pawlikowski; S Maj; B Nasiłowska
Journal:  Acta Pol Pharm       Date:  2000-11       Impact factor: 0.330

Review 3.  Dosing regimens and main adverse events of bisphosphonates.

Authors:  J J Body
Journal:  Semin Oncol       Date:  2001-08       Impact factor: 4.929
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.